This episode of Pharma Pulse discusses a new executive order to build a domestic API stockpile, Eli Lilly’s 170% price ...

As over half of Americans now receive prescriptions through Medicare or Medicaid, pharma companies must shift from a commercial-first approach to a statutory-first model, making GTN governance a ...

Two Labs’ Michael Rowe assesses the industry’s level of preparation, including challenges stakeholders have encountered along ...

The directive calls for building a six-month Strategic Active Pharmaceutical Ingredients Reserve, updating the essential ...

The US drug wholesaling industry is stable post-opioid settlement, with focus shifting to fund management and pharmacy ...

This episode of Pharma Pulse explores AbbVie’s $195 million investment to expand US API production, new survey results ...

In the second part of his Pharma Commerce video interview, Dave Malenfant, a healthcare supply chain expert, outlines how the impact of a steep pharmaceutical import tariff varies across raw materials ...

This episode of Pharma Pulse dives into Cardinal Health’s acquisition of Solaris Health to strengthen specialty services, how ...

This episode of Pharma Pulse covers Vinay Prasad’s return to lead the FDA’s biologics center after a brief resignation, new ...

Conversation with chief tech expert explores AI’s rise in the support space—and separating the substance from the noise.

Pharma must align data, personalization, and cross-functional orchestration to deliver human-centered experiences that ...

This episode of Pharma Pulse explores the FDA’s new proactive quality review initiative for drug manufacturing, GSK’s $370 ...